Edition:
United Kingdom

Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

7.65CNY
23 May 2018
Change (% chg)

¥-0.08 (-1.03%)
Prev Close
¥7.73
Open
¥7.72
Day's High
¥7.78
Day's Low
¥7.63
Volume
30,571,279
Avg. Vol
14,262,251
52-wk High
¥8.00
52-wk Low
¥6.15

Chart for

About

Zhejiang CONBA Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of traditional Chinese medicines, modern phytomedicines and chemical drugs. The Company also provides active ingredients. The Company's products include tablets, capsules, pills,... (more)
No analyst recommendations are available for .

Overall

Beta: 0.94
Market Cap(Mil.): ¥17,750.86
Shares Outstanding(Mil.): 2,510.73
Dividend: 0.12
Yield (%): 1.70

Financials

  600572.SS Industry Sector
P/E (TTM): 34.23 30.95 32.75
EPS (TTM): 0.21 -- --
ROI: 9.47 14.84 14.38
ROE: 11.97 16.34 16.07

BRIEF-Shanghai Exchange Filing Shows Block Trade Of Zhejiang Conba Pharmal Involving 372.36 Mln Yuan

* FILING SHOWS BLOCK TRADE OF ZHEJIANG CONBA PHARMACEUTICAL CO LTD'S 53.35 MILLION SHARES INVOLVING 372.36 MILLION YUAN ($58.56 million) ON MAY 2 Source text in Chinese: https://bit.ly/2yJZikT Further company coverage: ($1 = 6.3587 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

02 May 2018

BRIEF-Zhejiang CONBA Pharmaceutical to pay annual cash div as 1.50 yuan per 10 shares for FY 2017

* Says it plans to pay annual cash dividend as 1.50 yuan(pre-tax) per 10 shares as FY 2017 div payment

26 Apr 2018

BRIEF-Zhejiang Conba Pharmaceutical's 2017, Q1 Profit Up

* SAYS 2017 NET PROFIT UP 61.2 PERCENT Y/Y AT 711.1 MILLION YUAN ($112.45 million)

26 Apr 2018

BRIEF-Zhejiang Conba Pharmaceutical's Share Trade To Resume On April 18

* SAYS SHARE TRADE TO RESUME ON APRIL 18 Source text in Chinese: https://bit.ly/2HIphKM Further company coverage: (Reporting by Hong Kong newsroom)

17 Apr 2018

BRIEF-Zhejiang Conba Pharmaceutical's Consortium Acquires Stake In Jiangxi Chinese Medicine Firm

* SAYS ITS CONSORTIUM ACQUIRES 41 PERCENT STAKE IN JIANGXI CHINESE MEDICINE FIRM FOR 300.35 MILLION YUAN ($47.84 million) Source text in Chinese: https://bit.ly/2v9X0Kh Further company coverage: ($1 = 6.2785 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

13 Apr 2018

BRIEF-Zhejiang Conba Pharmaceutical Says Lock-Up Period For 446.25 Million Shares To End

* SAYS LOCK-UP PERIOD FOR 446.25 MILLION SHARES TO END, SHARES TO START TRADING ON APRIL 16 Source text in Chinese: https://bit.ly/2EA5Yjp Further company coverage: (Reporting by Hong Kong newsroom)

10 Apr 2018

BRIEF-Zhejiang CONBA Pharmaceutical to set up traditional Chinese medicinal materials unit in Zhejiang

* Says it plans to invest 100 million yuan to set up a wholly owned traditional Chinese medicinal materials unit in Zhejiang

13 Mar 2018

BRIEF-Zhejiang Conba Pharmaceutical issues 156.6 mln shares and raises 1.09 bln yuan

* Says it issued 156.6 million shares and raised 1.09 billion yuan in total, via private placement

12 Jan 2018

BRIEF-Zhejiang Conba Pharmaceutical Sees 2017 Net Profit Up 60-80 Percent Y/Y

* SAYS IT EXPECTS 2017 NET PROFIT TO RISE 60-80 PERCENT Y/Y FROM 441.1 MILLION YUAN ($67.65 million) YEAR AGO Source text in Chinese: http://bit.ly/2CRWSBQ Further company coverage: ($1 = 6.5205 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

09 Jan 2018

BRIEF-Zhejiang Conba Pharmaceutical two units obtains high-tech enterprise recognition

* Says its two wholly owned Guizhou and Inner Mongolia-based pharma units obtains high-tech enterprise recognition, to enjoy a tax preference of 15 percent for three years from 2017 to 2019

22 Dec 2017

Earnings vs. Estimates